002 FINAL SVMPharma RWE highlight infographic 03-01-2019

RWE roundup – December 2018

FDA FDA releases new strategic framework for assessing the potential use of RWE in connection with drug review program Click here to find out more   ASH Researchers identify nutation in BCL2 protein that causes resistance to venetoclax in progressive CLL Click here to find out more   NICE NICE recommends MSD’s Keytruda within the CDF […]

Read More